Pseudomonas aeruginosa exotoxin pyocyanin causes cystic fibrosis airway pathogenesis.

The cystic fibrosis (CF) airway bacterial pathogen Pseudomonas aeruginosa secretes multiple virulence factors. Among these, the redox active exotoxin pyocyanin (PCN) is produced in concentrations up to 100 mumol/L during infection of CF and other bronchiectatic airways. However, the contributions of PCN during infection of bronchiectatic airways are not appreciated. In this study, we demonstrate that PCN is critical for chronic infection in mouse airways and orchestrates adaptive immune responses that mediate lung damage. Wild-type FVBN mice chronically exposed to PCN developed goblet cell hyperplasia and metaplasia, airway fibrosis, and alveolar airspace destruction. Furthermore, after 12 weeks of exposure to PCN, mouse lungs down-regulated the expression of T helper (Th) type 1 cytokines and polarized toward a Th2 response. Cellular analyses indicated that chronic exposure to PCN profoundly increased the lung population of recruited macrophages, CD4(+) T cells, and neutrophils responsible for the secretion of these cytokines. PCN-mediated goblet cell hyperplasia and metaplasia required Th2 cytokine signaling through the Stat6 pathway. In summary, this study establishes that PCN is an important P. aeruginosa virulence factor capable of directly inducing pulmonary pathophysiology in mice, consistent with changes observed in CF and other bronchiectasis lungs.

[1]  M. Kolb,et al.  Role of STAT6 and SMAD2 in a model of chronic allergen exposure: a mouse strain comparison study , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[2]  Kyubo Kim,et al.  Mucus hypersecretion in asthma: causes and effects , 2009, Current opinion in pulmonary medicine.

[3]  Mark A. Miller,et al.  Identification of Francisella tularensis Lipoproteins That Stimulate the Toll-like Receptor (TLR) 2/TLR1 Heterodimer* , 2008, Journal of Biological Chemistry.

[4]  B. Ma,et al.  Inhibition of NF-κB Activation Reduces the Tissue Effects of Transgenic IL-131 , 2007, The Journal of Immunology.

[5]  B. Ma,et al.  Inhibition of NF-kappaB activation reduces the tissue effects of transgenic IL-13. , 2007, Journal of immunology.

[6]  J. Voynow,et al.  Respiratory tract mucin genes and mucin glycoproteins in health and disease. , 2006, Physiological reviews.

[7]  S. Phan,et al.  Molecular mechanisms of and possible treatment strategies for idiopathic pulmonary fibrosis. , 2005, Current pharmaceutical design.

[8]  D. Look,et al.  Pyocyanin and Its Precursor Phenazine-1-Carboxylic Acid Increase IL-8 and Intercellular Adhesion Molecule-1 Expression in Human Airway Epithelial Cells by Oxidant-Dependent Mechanisms1 , 2005, The Journal of Immunology.

[9]  D. Hassett,et al.  Modulation of lung epithelial functions by Pseudomonas aeruginosa. , 2005, Trends in microbiology.

[10]  D. Nivens,et al.  Calcium-Induced Virulence Factors Associated with the Extracellular Matrix of Mucoid Pseudomonas aeruginosa Biofilms , 2005, Journal of bacteriology.

[11]  F. Finkelman,et al.  Suppressive Effect of IL-4 on IL-13-Induced Genes in Mouse Lung1 , 2005, The Journal of Immunology.

[12]  Daniel G. Lee,et al.  Pyocyanin Production by Pseudomonas aeruginosa Induces Neutrophil Apoptosis and Impairs Neutrophil-Mediated Host Defenses In Vivo1 , 2005, The Journal of Immunology.

[13]  S. Phan,et al.  Animal models of pulmonary fibrosis. , 2005, Methods in molecular medicine.

[14]  R. Strieter,et al.  Mechanisms and mediators of pulmonary fibrosis. , 2005, Critical reviews in immunology.

[15]  D. Hassett,et al.  The role of pyocyanin in Pseudomonas aeruginosa infection. , 2004, Trends in molecular medicine.

[16]  K. Kuwano,et al.  The perforin mediated apoptotic pathway in lung injury and fibrosis , 2004, Journal of Clinical Pathology.

[17]  M. Burdick,et al.  The Role of the Th2 CC Chemokine Ligand CCL17 in Pulmonary Fibrosis1 , 2004, The Journal of Immunology.

[18]  R. Homer,et al.  Regulation of pulmonary fibrosis by chemokine receptor CXCR3. , 2004, The Journal of clinical investigation.

[19]  D. Hassett,et al.  Pseudomonas aeruginosa Pyocyanin Is Critical for Lung Infection in Mice , 2004, Infection and Immunity.

[20]  K. Kaestner,et al.  Foxa2 regulates alveolarization and goblet cell hyperplasia , 2004, Development.

[21]  F. Martinez,et al.  Mechanisms of pulmonary fibrosis. , 2004, Annual review of medicine.

[22]  N. Blin,et al.  IL-4 and IL-13 Up-Regulate Intestinal Trefoil Factor Expression: Requirement for STAT6 and De Novo Protein Synthesis , 2004 .

[23]  D. Hassett,et al.  Human targets of Pseudomonas aeruginosa pyocyanin , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Lian-Hui Zhang,et al.  Microbial diversity and prevalence of virulent pathogens in biofilms developed in a water reclamation system. , 2003, Research in microbiology.

[25]  P. Ohtake,et al.  Aberrant lung structure, composition, and function in a murine model of Hermansky-Pudlak syndrome. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[26]  G. Denning,et al.  Phenazine-1-carboxylic acid, a secondary metabolite of Pseudomonas aeruginosa, alters expression of immunomodulatory proteins by human airway epithelial cells. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[27]  Jae Young Choi,et al.  Interleukin-1β and Tumor Necrosis Factor-α Induce MUC5AC Overexpression through a Mechanism Involving ERK/p38 Mitogen-activated Protein Kinases-MSK1-CREB Activation in Human Airway Epithelial Cells* , 2003, Journal of Biological Chemistry.

[28]  Y. Ho,et al.  Stimulation of Airway Mucin Gene Expression by Interleukin (IL)-17 through IL-6 Paracrine/Autocrine Loop* , 2003, The Journal of Biological Chemistry.

[29]  J. Whitsett,et al.  Pneumonitis and Emphysema in sp-C Gene Targeted Mice* , 2003, The Journal of Biological Chemistry.

[30]  J. Alcorn,et al.  Pseudomonas aeruginosa elastase degrades surfactant proteins A and D. , 2003, American journal of respiratory cell and molecular biology.

[31]  R. Boucher,et al.  An overview of the pathogenesis of cystic fibrosis lung disease. , 2002, Advanced drug delivery reviews.

[32]  M. Muller,et al.  Pyocyanin induces oxidative stress in human endothelial cells and modulates the glutathione redox cycle. , 2002, Free radical biology & medicine.

[33]  Mark J. Smyth,et al.  Functional significance of the perforin/granzyme cell death pathway , 2002, Nature Reviews Immunology.

[34]  S. Kunkel,et al.  Airway hyperresponsiveness, but not airway remodeling, is attenuated during chronic pulmonary allergic responses to Aspergillus in CCR4‐/‐ mice , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  R. Vabulas,et al.  Bacterial CpG‐DNA and lipopolysaccharides activate Toll‐like receptors at distinct cellular compartments , 2002, European journal of immunology.

[36]  M. Borchers,et al.  CD4(+) T cell-dependent airway mucus production occurs in response to IL-5 expression in lung. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[37]  P. O'Byrne,et al.  Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[38]  Gerald B. Pier,et al.  Lung Infections Associated with Cystic Fibrosis , 2002, Clinical Microbiology Reviews.

[39]  G. Taylor,et al.  Induction of Neutrophil Apoptosis by the Pseudomonas aeruginosa Exotoxin Pyocyanin: A Potential Mechanism of Persistent Infection1 , 2002, The Journal of Immunology.

[40]  R. Puri,et al.  Stat6-deficient mice develop airway hyperresponsiveness and peribronchial fibrosis during chronic fungal asthma. , 2002, The American journal of pathology.

[41]  R. Homer,et al.  Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1 , 2001, The Journal of experimental medicine.

[42]  V. Kurup,et al.  IL-13 and IFN-γ: Interactions in Lung Inflammation1 , 2001, The Journal of Immunology.

[43]  J. Eyles,et al.  Tissue distribution of radioactivity following intranasal administration of radioactive microspheres , 2001, The Journal of pharmacy and pharmacology.

[44]  W. Foster,et al.  Methodology for the measurement of mucociliary function in the mouse by scintigraphy. , 2001, Journal of applied physiology.

[45]  W. Khan,et al.  Stat6 dependent goblet cell hyperplasia during intestinal nematode infection , 2001, Parasite immunology.

[46]  Matthew R. Parsek,et al.  Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms , 2000, Nature.

[47]  J. Jen,et al.  Interleukin-9 upregulates mucus expression in the airways. , 2000, American journal of respiratory cell and molecular biology.

[48]  K. Dabbagh,et al.  Oxidative Stress Causes Mucin Synthesis Via Transactivation of Epidermal Growth Factor Receptor: Role of Neutrophils1 , 2000, The Journal of Immunology.

[49]  N. Letwin,et al.  Model systems for investigating mucin gene expression in airway diseases. , 2000, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[50]  S. Wenzel,et al.  Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells. , 1999, The Journal of clinical investigation.

[51]  C. D. Cox,et al.  The Pseudomonas aeruginosa Secretory Product Pyocyanin Inactivates α1 Protease Inhibitor: Implications for the Pathogenesis of Cystic Fibrosis Lung Disease , 1999, Infection and Immunity.

[52]  K. Kuwano,et al.  The involvement of Fas-Fas ligand pathway in fibrosing lung diseases. , 1999, American journal of respiratory cell and molecular biology.

[53]  C. Mackay,et al.  Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. , 1998, Immunology today.

[54]  W. Abraham,et al.  Mechanism of pyocyanin- and 1-hydroxyphenazine-induced lung neutrophilia in sheep airways. , 1998, Journal of applied physiology.

[55]  L. Stoll,et al.  Pseudomonas Pyocyanin Increases Interleukin-8 Expression by Human Airway Epithelial Cells , 1998, Infection and Immunity.

[56]  Jian-Dong Li,et al.  Activation of NF-kappaB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[57]  J. Costerton,et al.  The involvement of cell-to-cell signals in the development of a bacterial biofilm. , 1998, Science.

[58]  T. Sorrell,et al.  Modulation of neutrophil superoxide response and intracellular diacylglyceride levels by the bacterial pigment pyocyanin , 1997, Infection and immunity.

[59]  B. Stripp,et al.  Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[60]  C. D. Cox,et al.  Pyocyanin from Pseudomonas aeruginosa inhibits prostacyclin release from endothelial cells , 1995, Infection and immunity.

[61]  T. Sorrell,et al.  Inhibition of Platelet Eicosanoid Metabolism by the Bacterial Phenazine Derivative Pyocyanin , 1994, Annals of the New York Academy of Sciences.

[62]  W. Abraham,et al.  Extracellular metabolites of Pseudomonas aeruginosa produce bronchoconstriction by different mechanisms. , 1994, American journal of respiratory and critical care medicine.

[63]  C. D. Cox,et al.  Interaction of the Pseudomonas aeruginosa secretory products pyocyanin and pyochelin generates hydroxyl radical and causes synergistic damage to endothelial cells. Implications for Pseudomonas-associated tissue injury. , 1992, The Journal of clinical investigation.

[64]  J. Shellito,et al.  Effect of pyocyanine, a pigment of Pseudomonas aeruginosa, on production of reactive nitrogen intermediates by murine alveolar macrophages , 1992, Infection and immunity.

[65]  T. Sorrell,et al.  Leukotriene B4 omega-oxidation by human polymorphonuclear leukocytes is inhibited by pyocyanin, a phenazine derivative produced by Pseudomonas aeruginosa , 1992, Infection and immunity.

[66]  G. Taylor,et al.  Effect of Pseudomonas aeruginosa-derived pyocyanin and 1-hydroxyphenazine on pulmonary mucociliary clearance monitored scintigraphically in the baboon model. , 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[67]  R. Wilson,et al.  Effect of pyocyanin and 1-hydroxyphenazine on in vivo tracheal mucus velocity. , 1989, Journal of applied physiology.

[68]  G. Taylor,et al.  Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium , 1988, Infection and immunity.

[69]  D. Hyde,et al.  Effect of murine gamma interferon on the cellular responses to bleomycin in mice. , 1988, Experimental lung research.

[70]  D. Dearborn,et al.  Studies on the mechanism of T cell inhibition by the Pseudomonas aeruginosa phenazine pigment pyocyanine. , 1987, Journal of immunology.

[71]  B. Holloway,et al.  Chromosomal genetics of Pseudomonas. , 1979, Microbiological reviews.

[72]  Thurlbeck Wm Measurement of pulmonary emphysema. , 1967 .

[73]  W. Thurlbeck Measurement of pulmonary emphysema. , 1967, The American review of respiratory disease.

[74]  King Eo,et al.  Two simple media for the demonstration of pyocyanin and fluorescin. , 1954 .

[75]  E. King,et al.  Two simple media for the demonstration of pyocyanin and fluorescin. , 1954, The Journal of laboratory and clinical medicine.